566 related articles for article (PubMed ID: 15606374)
41. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism.
Versnick M; Popadich A; Sidhu S; Sywak M; Robinson B; Delbridge L
Surgery; 2013 Jul; 154(1):101-5. PubMed ID: 23809488
[TBL] [Abstract][Full Text] [Related]
42. [Surgical approach in the treatment of recurrent primary hyperparathyroidism].
Lumachi F; Favia G; D'Amico DF
Ann Ital Chir; 1993; 64(4):371-3. PubMed ID: 8154659
[TBL] [Abstract][Full Text] [Related]
43. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
[TBL] [Abstract][Full Text] [Related]
44. Radioguided parathyroidectomy in patients with familial hyperparathyroidism.
Lal A; Bianco J; Chen H
Ann Surg Oncol; 2007 Feb; 14(2):739-43. PubMed ID: 17122990
[TBL] [Abstract][Full Text] [Related]
45. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.
Barczynski M; Konturek A; Cichon S; Hubalewska-Dydejczyk A; Golkowski F; Huszno B
Clin Endocrinol (Oxf); 2007 Jun; 66(6):878-85. PubMed ID: 17437518
[TBL] [Abstract][Full Text] [Related]
46. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
47. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
[TBL] [Abstract][Full Text] [Related]
48. Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1.
Salmeron MD; Gonzalez JM; Sancho Insenser J; Goday A; Perez NM; Zambudio AR; Paricio PP; Serra AS
World J Surg; 2010 Jun; 34(6):1325-31. PubMed ID: 20431882
[TBL] [Abstract][Full Text] [Related]
49. A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Lairmore TC; Govednik CM; Quinn CE; Sigmond BR; Lee CY; Jupiter DC
Surgery; 2014 Dec; 156(6):1326-34; discussion 1334-5. PubMed ID: 25262224
[TBL] [Abstract][Full Text] [Related]
50. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.
Haustein SV; Mack E; Starling JR; Chen H
Surgery; 2005 Dec; 138(6):1066-71; discussion 1071. PubMed ID: 16360392
[TBL] [Abstract][Full Text] [Related]
51. Is focused minimally invasive parathyroidectomy appropriate for patients with familial primary hyperparathyroidism?
Prichard RS; O'Neill CJ; Oucharek JJ; Sippel RS; Delbridge LW; Sidhu SB; Chen H
Ann Surg Oncol; 2012 Apr; 19(4):1264-8. PubMed ID: 21989662
[TBL] [Abstract][Full Text] [Related]
52. Familial hyperparathyroidism.
Takami H; Shirahama S; Ikeda Y; Sasaki Y; Wada N; Niimi M; Kameyama K
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():21s-24s. PubMed ID: 10914986
[TBL] [Abstract][Full Text] [Related]
53. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Waldmann J; López CL; Langer P; Rothmund M; Bartsch DK
Br J Surg; 2010 Oct; 97(10):1528-34. PubMed ID: 20629112
[TBL] [Abstract][Full Text] [Related]
54. The utility of a rapid parathyroid assay for uniglandular, multiglandular, and recurrent parathyroid disease.
Arciero CA; Peoples GE; Stojadinovic A; Shriver CD
Am Surg; 2004 Jul; 70(7):588-92. PubMed ID: 15279180
[TBL] [Abstract][Full Text] [Related]
55. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.
Mittendorf EA; Merlino JI; McHenry CR
Am Surg; 2004 Feb; 70(2):114-9; discussion 119-20. PubMed ID: 15011912
[TBL] [Abstract][Full Text] [Related]
56. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?
Ning L; Sippel R; Schaefer S; Chen H
Ann Surg; 2009 Mar; 249(3):469-72. PubMed ID: 19247036
[TBL] [Abstract][Full Text] [Related]
57. Primary hyperparathyroidism and familial hyperparathyroid syndromes.
Blackburn M; Diamond T
Aust Fam Physician; 2007 Dec; 36(12):1029-33. PubMed ID: 18075629
[TBL] [Abstract][Full Text] [Related]
58. Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery.
Phillips IJ; Kurzawinski TR; Honour JW
Ann Clin Biochem; 2005 Nov; 42(Pt 6):453-8. PubMed ID: 16259796
[TBL] [Abstract][Full Text] [Related]
59. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
60. [The role of intraoperative parathyroid hormone assay in the surgical management of hyperparathyroidism].
Romani AM; Panarese A; La Torre V; Pironi D; Sardella D; Mancini E; Mazzaferro S; Arcieri S; Filippini A
Ann Ital Chir; 2007; 78(2):91-6. PubMed ID: 17583117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
